Sasmita Poudel Adhikari, Sha Meng, Yuju Wu, Yuping Mao, Ruixue Ye, Qingzhi Wang, Chang Sun, Sean Sylvia, Scott Rozelle, Hein Raat, Huan Zhou
Background The coronavirus disease (COVID-19) has been identified as the cause of an outbreak of respiratory illness in Wuhan, Hubei Province, China beginning in December 2019.
The adjusted mortality for care teams with anesthesiologist assistants was 1.6% (95% CI, 1.4 to 1.8) versus 1.7% for care teams with nurse anesthetists (95% CI, 1.7 to 1.7; difference −0.08; 95% CI...
Nagamani Kammili, Jyothi Lakshmi, Anlu Xing, Afia Khan, Manisha Rani, Prasanthi Kolli, Anlu Xing, Douglas K. Owens
The decreasing effectiveness of antimicrobial agents is a global public health threat, yet risk factors for community-acquired antimicrobial resistance (CA-AMR) in low-income settings have not been...
Institute of Medicine's Committee on Comparative Effectiveness Research Prioritization, Alan M. Garber
Clinical research presents health care providers with information on the natural history and clinical presentations of disease as well as diagnostic and treatment options.
Caughey AB, Vandana Sundaram, Kaimal AJ, Cheng YW, Allison Gienger, Little SE, Lee JF
Lee JF, Shaffer BL
Shaffer BL
, Tran SH, Padula A, Kathryn M. McDonald, Long EF, Douglas Owens, Dena Bravata
Background: Induction of labor is on the rise in the U.S., increasing from 9.5 percent in 1990 to 22.1 percent in 2004.
Most Americans don’t realize there are silent brokers helping to fix the price of their prescription drugs — or that it’s a $100 billion annual business accounting for half of Big Pharma sales.
We asked Stanford Health Policy's Michelle Mello — a professor of medicine and law — to answer some questions about the federal rollout of diagnostic testing for the coronavirus.
Nuclear energy production today and in the near future will still be dominated by light-water reactors and therefore there will be a continued need for uranium enrichment.
Audio and transcript from the Asia Health Policy Program seminar, "The Impact of Taiwan's National Health Insurance's 20-year Journey: How has the market responded and will respond?" on April 19, 2016, with Karen Eggleston, Jui-fen Rachel Lu and...
Audio and transcript from the Asia Health Policy Program seminar "Impact of China’s ‘Zero-markup Policy for Essential Drugs’ on Patients, County Hospital Revenue and Government Subsidy Levels" on April 5, 2016, with Yanfang Su.China implemented a...
Audio, transcript and presentation from the Asia Health Policy Program seminar "Trends in Disability in a Super-Aging Society: Adapting the Future Elderly Model to Japan" on Oct.
